Long-term net clinical benefit in favor of fondaparinux compared with enoxaparin in European patients with non-ST elevation acute coronary syndromes: a subgroup analysis of OASIS-5 Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • September 1, 2008